Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma. [electronic resource] by
- Mina, Marco
- Boldrini, Renata
- Citti, Arianna
- Romania, Paolo
- D'Alicandro, Valerio
- De Ioris, Maretta
- Castellano, Aurora
- Furlanello, Cesare
- Locatelli, Franco
- Fruci, Doriana
Publication details: Oncoimmunology Sep 2015
In:
Oncoimmunology vol. 4
Availability: No items available.
|
|
11.
|
|
|
12.
|
|
|
13.
|
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma. [electronic resource] by
- Brandetti, Elisa
- Veneziani, Irene
- Melaiu, Ombretta
- Pezzolo, Annalisa
- Castellano, Aurora
- Boldrini, Renata
- Ferretti, Elisa
- Fruci, Doriana
- Moretta, Lorenzo
- Pistoia, Vito
- Locatelli, Franco
- Cifaldi, Loredana
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 6
Availability: No items available.
|
|
14.
|
Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma. [electronic resource] by
- Di Cataldo, Andrea
- Dau, Daniela
- Conte, Massimo
- Parodi, Stefano
- De Bernardi, Bruno
- Giuliano, Maria
- Pession, Andrea
- Viscardi, Elisabetta
- Luksch, Roberto
- Castellano, Aurora
- Bertuna, Gregoria
- Haupt, Riccardo
Producer: 20090316
In:
Medical science monitor : international medical journal of experimental and clinical research vol. 15
Availability: No items available.
|
|
15.
|
Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: pharmacological rationale and clinical response. [electronic resource] by
- Donfrancesco, Alberto
- De Ioris, Maria Antonietta
- McDowell, Heather Prudence
- De Pasquale, Maria Debora
- Ilari, Ilaria
- Jenkner, Alessandro
- Castellano, Aurora
- Cialfi, Samantha
- De Laurentis, Clementina
- Dominici, Carlo
Producer: 20091217
In:
Pediatric blood & cancer vol. 54
Availability: No items available.
|
|
16.
|
A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma. [electronic resource] by
- Calabrese, Francesco Maria
- Clima, Rosanna
- Pignataro, Piero
- Lasorsa, Vito Alessandro
- Hogarty, Michael D
- Castellano, Aurora
- Conte, Massimo
- Tonini, Gian Paolo
- Iolascon, Achille
- Gasparre, Giuseppe
- Capasso, Mario
Producer: 20180221
In:
Oncotarget vol. 7
Availability: No items available.
|
|
17.
|
High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma. [electronic resource] by
- Romania, Paolo
- Castellano, Aurora
- Surace, Cecilia
- Citti, Arianna
- De Ioris, Maria Antonietta
- Sirleto, Pietro
- De Mariano, Marilena
- Longo, Luca
- Boldrini, Renata
- Angioni, Adriano
- Locatelli, Franco
- Fruci, Doriana
Producer: 20150223
In:
PloS one vol. 8
Availability: No items available.
|
|
18.
|
Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma. [electronic resource] by
- Capasso, Mario
- Lasorsa, Vito Alessandro
- Cimmino, Flora
- Avitabile, Marianna
- Cantalupo, Sueva
- Montella, Annalaura
- De Angelis, Biagio
- Morini, Martina
- de Torres, Carmen
- Castellano, Aurora
- Locatelli, Franco
- Iolascon, Achille
Producer: 20200817
In:
Cancer research vol. 80
Availability: No items available.
|
|
19.
|
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. [electronic resource] by
- Melaiu, Ombretta
- Mina, Marco
- Chierici, Marco
- Boldrini, Renata
- Jurman, Giuseppe
- Romania, Paolo
- D'Alicandro, Valerio
- Benedetti, Maria C
- Castellano, Aurora
- Liu, Tao
- Furlanello, Cesare
- Locatelli, Franco
- Fruci, Doriana
Producer: 20180619
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
20.
|
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma. [electronic resource] by
- Morandi, Fabio
- Amoroso, Loredana
- Dondero, Alessandra
- Castriconi, Roberta
- Parodi, Stefano
- Luksch, Roberto
- Casale, Fiorina
- Castellano, Aurora
- Garaventa, Alberto
- Moretta, Alessandro
- Bottino, Cristina
- Ponzoni, Mirco
- Corrias, Maria Valeria
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 7
Availability: No items available.
|